186 related articles for article (PubMed ID: 34818133)
1. Neighborhood-Level Disadvantage Impacts on Patients with Fibrotic Interstitial Lung Disease.
Goobie GC; Ryerson CJ; Johannson KA; Schikowski E; Zou RH; Khalil N; Marcoux V; Assayag D; Manganas H; Fisher JH; Kolb MRJ; Gibson KF; Kass DJ; Zhang Y; Lindell KO; Nouraie SM
Am J Respir Crit Care Med; 2022 Feb; 205(4):459-467. PubMed ID: 34818133
[No Abstract] [Full Text] [Related]
2. Real-life experiences in a single center: efficacy of pirfenidone in idiopathic pulmonary fibrosis and fibrotic idiopathic non-specific interstitial pneumonia patients.
Feng H; Zhao Y; Li Z; Kang J
Ther Adv Respir Dis; 2020; 14():1753466620963015. PubMed ID: 33070705
[TBL] [Abstract][Full Text] [Related]
3. Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases.
Salonen J; Purokivi M; Bloigu R; Kaarteenaho R
BMJ Open Respir Res; 2020 Apr; 7(1):. PubMed ID: 32265195
[TBL] [Abstract][Full Text] [Related]
4. Incidence and Prognostic Significance of Hypoxemia in Fibrotic Interstitial Lung Disease: An International Cohort Study.
Khor YH; Gutman L; Abu Hussein N; Johannson KA; Glaspole IN; Guler SA; Funke-Chambour M; Geiser T; Goh NSL; Ryerson CJ
Chest; 2021 Sep; 160(3):994-1005. PubMed ID: 33905679
[TBL] [Abstract][Full Text] [Related]
5. Acute exacerbations of fibrotic interstitial lung diseases.
Suzuki A; Kondoh Y; Brown KK; Johkoh T; Kataoka K; Fukuoka J; Kimura T; Matsuda T; Yokoyama T; Fukihara J; Ando M; Tanaka T; Hashimoto N; Sakamoto K; Hasegawa Y
Respirology; 2020 May; 25(5):525-534. PubMed ID: 31426125
[TBL] [Abstract][Full Text] [Related]
6. Neighborhood Socioeconomic Disadvantage, Healthcare Access, and Outcomes of Hospitalizations for Common Pulmonary Conditions: A National Study of Medicare Beneficiaries.
Lusk JB; Hoffman MN; Clark AG; Mahoney H; Blass B; Bae J; Ashana DC; Cox CE; Hammill BG
Ann Am Thorac Soc; 2023 Oct; 20(10):1416-1424. PubMed ID: 37343304
[No Abstract] [Full Text] [Related]
7. Ambient Ultrafine Particulate Matter and Clinical Outcomes in Fibrotic Interstitial Lung Disease.
Goobie GC; Saha PK; Carlsten C; Gibson KF; Johannson KA; Kass DJ; Ryerson CJ; Zhang Y; Robinson AL; Presto AA; Nouraie SM
Am J Respir Crit Care Med; 2024 May; 209(9):1082-1090. PubMed ID: 38019094
[No Abstract] [Full Text] [Related]
8. Community-level social determinants of health and pregestational and gestational diabetes.
Field C; Grobman WA; Yee LM; Johnson J; Wu J; McNeil B; Mercer B; Simhan H; Reddy U; Silver RM; Parry S; Saade G; Chung J; Wapner R; Lynch CD; Venkatesh KK
Am J Obstet Gynecol MFM; 2024 Feb; 6(2):101249. PubMed ID: 38070680
[TBL] [Abstract][Full Text] [Related]
9. A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease.
Wong AW; Lee TY; Johannson KA; Assayag D; Morisset J; Fell CD; Fisher JH; Shapera S; Gershon AS; Cox G; Halayko AJ; Hambly N; Manganas H; Sadatsafavi M; Wilcox PG; To T; Marcoux V; Khalil N; Kolb M; Ryerson CJ
Respir Res; 2020 Dec; 21(1):322. PubMed ID: 33287805
[TBL] [Abstract][Full Text] [Related]
10. Neighborhood Health and Outcomes in Idiopathic Pulmonary Fibrosis.
DeDent AM; Collard HR; Thakur N
Ann Am Thorac Soc; 2024 Mar; 21(3):402-410. PubMed ID: 37962494
[No Abstract] [Full Text] [Related]
11. Prevalence and prognosis of chronic fibrosing interstitial lung diseases with a progressive phenotype.
Takei R; Brown KK; Yamano Y; Kataoka K; Yokoyama T; Matsuda T; Kimura T; Suzuki A; Furukawa T; Fukuoka J; Johkoh T; Goto Y; Kondoh Y
Respirology; 2022 May; 27(5):333-340. PubMed ID: 35293077
[TBL] [Abstract][Full Text] [Related]
12. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H
Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371
[TBL] [Abstract][Full Text] [Related]
13. Neighborhood disadvantage and racial disparities in colorectal cancer incidence: a population-based study in Louisiana.
Danos DM; Ferguson TF; Simonsen NR; Leonardi C; Yu Q; Wu XC; Scribner RA
Ann Epidemiol; 2018 May; 28(5):316-321.e2. PubMed ID: 29678311
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of the COPD Assessment Test in fibrotic interstitial lung disease.
Matsuda T; Kondoh Y; Furukawa T; Suzuki A; Takei R; Sasano H; Yamano Y; Yokoyama T; Kataoka K; Kimura T
Respir Investig; 2022 Jan; 60(1):99-107. PubMed ID: 34548272
[TBL] [Abstract][Full Text] [Related]
15. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
[TBL] [Abstract][Full Text] [Related]
16. Costs of Workplace Productivity Loss in Patients With Fibrotic Interstitial Lung Disease.
Algamdi M; Sadatsafavi M; Fisher JH; Morisset J; Johannson KA; Fell CD; Kolb M; Manganas H; Cox G; Gershon AS; Halayko AJ; Hambly N; Khalil N; Shapera S; To T; Wilcox PG; Guler S; Ryerson CJ
Chest; 2019 Nov; 156(5):887-895. PubMed ID: 31051170
[TBL] [Abstract][Full Text] [Related]
17. Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA.
Olson AL; Maher TM; Acciai V; Mounir B; Quaresma M; Zouad-Lejour L; Wells CD; De Loureiro L
Adv Ther; 2020 Jul; 37(7):3292-3298. PubMed ID: 32451950
[TBL] [Abstract][Full Text] [Related]
18. Neighborhood Socioeconomic Disadvantage and Care After Myocardial Infarction in the National Cardiovascular Data Registry.
Udell JA; Desai NR; Li S; Thomas L; de Lemos JA; Wright-Slaughter P; Zhang W; Roe MT; Bhatt DL
Circ Cardiovasc Qual Outcomes; 2018 Jun; 11(6):e004054. PubMed ID: 29848476
[TBL] [Abstract][Full Text] [Related]
19. Associations between Patient-reported Outcomes and Death or Lung Transplant in Idiopathic Pulmonary Fibrosis. Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry.
Case AH; Hellkamp AS; Neely ML; Bender S; Dilling DF; Gulati M; Hotchkin DL; Huie TJ; Lancaster L; Snyder LD; Conoscenti CS; Palmer SM
Ann Am Thorac Soc; 2020 Jun; 17(6):699-705. PubMed ID: 32040340
[No Abstract] [Full Text] [Related]
20. Association of County-degree Social Vulnerability with Chronic Respiratory Disease Mortality in the United States.
Lee YC; Chang KY; Mirsaeidi M
Ann Am Thorac Soc; 2023 Jan; 20(1):47-57. PubMed ID: 36044720
[No Abstract] [Full Text] [Related]
[Next] [New Search]
